SCHEDULE: Saba Capital Boosts BlackRock Tech Trust Stake to 7.94%

Saba Capital Management, L.P. and its affiliates have increased their beneficial ownership in BlackRock Science & Technology Term Trust to 7.94% through recent open market transactions.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") jointly filed an Amendment No. 10 to Schedule 13D.
• The Reporting Persons beneficially own 5,458,908 Common Shares of BlackRock Science & Technology Term Trust.
• This ownership represents 7.94% of the issuer's common stock, calculated based on 68,744,150 shares outstanding as of December 31, 2025, as disclosed in the company's N-CSR filed on March 5, 2026.
• Approximately $93,845,617 was paid to acquire the reported Common Shares.
• Funds for the purchases were derived from investor subscription proceeds, capital appreciation, and margin account borrowings.
• Transactions between January 15, 2026, and March 13, 2026, included both open market purchases and sales, as detailed in Schedule A.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development for BlackRock Science & Technology Term Trust shareholders, as a significant stake by an activist investor like Saba Capital often signals potential future actions to enhance shareholder value, despite the 'Not Applicable' purpose statement in this amendment.

Positives

• Saba Capital Management, a prominent investment manager known for its activist strategies, has increased its stake, potentially signaling confidence in BlackRock Science & Technology Term Trust.
• The total investment of approximately $93.8 million indicates a significant commitment by Saba Capital.

Risks

• The use of margin account borrowings for share purchases introduces leverage risk, as positions held in margin accounts are pledged as collateral security for the repayment of debit balances.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the issuer or the reporting persons regarding the future performance of BlackRock Science & Technology Term Trust or Saba Capital's investment strategy beyond the disclosure of their current holdings.

Industry Context

StockSavvy.ai notes that increased stakes by activist investors like Saba Capital in closed-end funds (CEFs) often precede calls for corporate governance changes, share repurchases, or other actions aimed at narrowing discounts to net asset value (NAV). While this filing states 'Purpose of Transaction: Not Applicable,' Saba Capital's history suggests a potential for future engagement, aligning with broader trends of activist pressure in the CEF space to unlock shareholder value.

Comparison to Industry Standards

• Saba Capital Management is known for its activist strategies in the closed-end fund sector, often targeting funds trading at a discount to NAV. Their 7.94% stake in BlackRock Science & Technology Term Trust is a significant position, comparable to other activist stakes taken in CEFs such as their past engagements with Western Asset Global Corporate Defined Opportunity Fund Inc. or Nuveen funds.
• The investment amount of approximately $93.8 million is substantial for a single position within a closed-end fund, indicating a high conviction play, similar to other large institutional investments in specialized funds.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if Saba Capital initiates activist strategies to narrow the fund's discount to NAV.
• Management: May face increased scrutiny or pressure from Saba Capital regarding fund performance, distribution policies, or governance.

Key Dates

Recommendation

While Saba Capital's increased stake could signal future activist engagement, the filing itself does not detail any specific plans or immediate catalysts for significant price movement beyond the market's reaction to the ownership disclosure. Investors should hold and monitor for any subsequent activist proposals or changes in the fund's discount to NAV.

Keywords

Saba Capital Management, BlackRock Science & Technology Term Trust, Schedule 13D, Beneficial Ownership, Institutional Investor, Closed-End Fund, Technology Investment, Equity Stake, Investment Management, SEC Filing